KALYN JORDAN: Open Payments
NPI 1285331363 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 83 payments from 15 companies in 2025. Trend: 2023 $969 · 2024 $1,950 · 2025 $1,966
Food & beverage: $1,881Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $423 |
| ABBVIE INC. | 21 | $351 |
| Regeneron Healthcare Solutions, Inc. | 7 | $221 |
| Amgen Inc. | 5 | $158 |
| Janssen Biotech, Inc. | 10 | $157 |
| UCB, Inc. | 5 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Lilly USA, LLC | 4 | $94 |
| Incyte Corporation | 3 | $73 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
Products named: DUPIXENT, RINVOQ, OTEZLA, TREMFYA, Bimzelx, SKYRIZI, TALTZ, COSENTYX.
Industry payments across FL — which companies pay providers there.
